Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)
Titel:
Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)
Auteur:
Gibson, C. Michael Bahit, M. Cecilia Mehran, Roxana Mehta, Shamir R. Lamee, Rasha Al Goto, Shinya Weitz, Jeffrey I. Horrow, Jay Barnathan, Elliot S. Harrington, Robert A. Mahaffey, Kenneth W. Lam, Carolyn S.P. Pieper, Karen S. Johnston, S. Claiborne Hankey, Graeme J. Plotnikov, Alexei N. Li, Danshi Deng, Hsiaowei Steg, Philippe Gabriel